Zachary K. Goldsmith, et al. “In Uveal Melanoma, Sirtuin Inhibitor As a New Cell Cycle Checkpoint and TP53-MDM2 Pathway Regulator”. The Ophthalmology, Dec. 2024, pp. 21-30, https://openventio.us/index.php/TOOJ/article/view/1178.